The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2015

Filed:

Nov. 24, 2011
Applicants:

Rajesh Thotapally, Pune, IN;

Onkar Gangaram Kachi, Pune, IN;

Atish Harishchandra Rodge, Pune, IN;

Ashok Bhau Pathak, Pune, IN;

Bhavana Shrirang Kardile, Pune, IN;

Milind Dattatraya Sindkhedkar, Pune, IN;

Venkata P. Palle, Pune, IN;

Rajender Kumar Kamboj, Pune, IN;

Assignee:

Lupin Limited, Mumbai, Maharashtra, IN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 471/04 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 31/454 (2006.01); A61K 31/437 (2006.01); A61K 31/4545 (2006.01); A61K 31/155 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 491/08 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 491/08 (2013.01); A61K 31/155 (2013.01); A61K 31/437 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to compounds of Formula (I) that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of GPR119 receptor activity. The invention also relates to the process for preparation of the compounds, pharmaceutical compositions thereof. The invention further relates to methods of treating, preventing and/or managing diseases, disorders syndromes or conditions associated with the modulation of GPR119 receptor by using either alone or in combinations of Formula (I).


Find Patent Forward Citations

Loading…